Ethyl 2-((2-(tert-butyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-yl)amino)-2-oxoacetate

Catalog No. :
ACKDTD375
CAS No. :
1105189-85-2
Molecular Formula :
C13H19N3O3S
Molecular Weight :
297.38

IUPAC Name:ethyl 2-((2-(tert-butyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-yl)amino)-2-oxoacetate

Ethyl 2-((2-(tert-butyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-yl)amino)-2-oxoacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-((2-(tert-butyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-yl)amino)-2-oxoacetate
IUPAC Nameethyl 2-((2-(tert-butyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-yl)amino)-2-oxoacetate
Molecular FormulaC13H19N3O3S
Molecular Weight297.38
SMILESO=C(OCC)C(NC1=C2C(CSC2)=NN1C(C)(C)C)=O
InChI KeySJTGMCYRFGAIDI-UHFFFAOYSA-N
Synonymethyl [(2-tert-butyl-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-yl)amino](oxo)acetate;Acetic acid, 2-[[2-(1,1-dimethylethyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-yl]amino]-2-oxo-, ethyl ester
CAS No.1105189-85-2

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H319-H372-H410
Precautionary Statement(s)
P260-P264-P273-P301+P312-P305+P351+P338-P314

Synthetic Route by SureRoute

1. ACKDTD375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKDTD375 route product structure diagram
    ACKDTD3751105189-85-2
Inquiry

2. ACKDTD375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKDTD375 route product structure diagram
    ACKDTD3751105189-85-2
Inquiry

Comments (0)